These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6151684

  • 1. Target antigens in malaria transmission blocking immunity.
    Carter R, Miller LH, Rener J, Kaushal DC, Kumar N, Graves PM, Grotendorst CA, Gwadz RW, French C, Wirth D.
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov 13; 307(1131):201-13. PubMed ID: 6151684
    [Abstract] [Full Text] [Related]

  • 2. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.
    Quakyi IA, Carter R, Rener J, Kumar N, Good MF, Miller LH.
    J Immunol; 1987 Dec 15; 139(12):4213-7. PubMed ID: 2447164
    [Abstract] [Full Text] [Related]

  • 3. A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies.
    Grotendorst CA, Kumar N, Carter R, Kaushal DC.
    Infect Immun; 1984 Sep 15; 45(3):775-7. PubMed ID: 6540756
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine.
    Kou X, Zheng W, Du F, Liu F, Wang M, Fan Q, Cui L, Luo E, Cao Y.
    Parasit Vectors; 2016 Apr 02; 9():190. PubMed ID: 27038925
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recent progress in the development of malaria vaccines: memorandum from a WHO meeting.
    Bull World Health Organ; 1984 Apr 02; 62(5):715-27. PubMed ID: 6391715
    [Abstract] [Full Text] [Related]

  • 7. Phase separation in Triton X-114 of antigens of transmission blocking immunity in Plasmodium gallinaceum.
    Kumar N.
    Mol Biochem Parasitol; 1985 Dec 02; 17(3):343-58. PubMed ID: 2867467
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with purified microgamete antigens prevents transmission of rodent malaria.
    Harte PG, Rogers N, Targett GA.
    Nature; 1985 Dec 02; 316(6025):258-9. PubMed ID: 4022122
    [Abstract] [Full Text] [Related]

  • 9. Mosquito stage, transmission blocking vaccines for malaria.
    Saul A.
    Curr Opin Infect Dis; 2007 Oct 02; 20(5):476-81. PubMed ID: 17762780
    [Abstract] [Full Text] [Related]

  • 10. Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.
    Mendis KN, Munesinghe YD, de Silva YN, Keragalla I, Carter R.
    Infect Immun; 1987 Feb 02; 55(2):369-72. PubMed ID: 2879793
    [Abstract] [Full Text] [Related]

  • 11. Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines.
    Mendis KN, David PH, Carter R.
    Int J Parasitol; 1990 Jul 02; 20(4):497-502. PubMed ID: 2210943
    [Abstract] [Full Text] [Related]

  • 12. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes.
    Tachibana M, Ishino T, Tsuboi T, Torii M.
    Vaccine; 2018 Nov 26; 36(49):7463-7471. PubMed ID: 30420038
    [Abstract] [Full Text] [Related]

  • 13. Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. III. Changes in zygote surface proteins during transformation to mature ookinete.
    Carter R, Kaushal DC.
    Mol Biochem Parasitol; 1984 Oct 26; 13(2):235-41. PubMed ID: 6151115
    [Abstract] [Full Text] [Related]

  • 14. Immunity to sexual stages of human malaria parasites: immune modulation during natural infections, antigenic determinants, and the induction of transmission-blocking immunity.
    Targett G.
    Scand J Infect Dis Suppl; 1990 Oct 26; 76():79-88. PubMed ID: 1714627
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. II. Comparison of surface antigens of male and female gametes and zygotes.
    Kaushal DC, Carter R.
    Mol Biochem Parasitol; 1984 Apr 26; 11():145-56. PubMed ID: 6146930
    [Abstract] [Full Text] [Related]

  • 17. Malaria vaccine.
    Khurana SK, Talib VH.
    Indian J Pathol Microbiol; 1996 Dec 26; 39(5):433-41. PubMed ID: 9002371
    [Abstract] [Full Text] [Related]

  • 18. Purification and production of Plasmodium falciparum zygotes from in vitro culture using magnetic column and Percoll density gradient.
    Zhou Y, Grieser AM, Do J, Itsara LS, Vaughan AM, Ghosh AK.
    Malar J; 2020 May 25; 19(1):192. PubMed ID: 32450861
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.
    Kaushal DC, Carter R, Rener J, Grotendorst CA, Miller LH, Howard RJ.
    J Immunol; 1983 Nov 25; 131(5):2557-62. PubMed ID: 6631012
    [Abstract] [Full Text] [Related]

  • 20. The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
    Sala KA, Nishiura H, Upton LM, Zakutansky SE, Delves MJ, Iyori M, Mizutani M, Sinden RE, Yoshida S, Blagborough AM.
    Vaccine; 2015 Jan 09; 33(3):437-45. PubMed ID: 25454088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.